2015
DOI: 10.3109/0886022x.2015.1077311
|View full text |Cite
|
Sign up to set email alerts
|

The relation between neutrophil–lymphocyte ratio and acute kidney injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 12 publications
(13 reference statements)
0
2
0
Order By: Relevance
“…It can be caused either by heart infection (such as infectious endocarditis) or other chronic infectious diseases (COPD). In clinical practice, the neutrophil to lymphocyte ratio (NLR) is an easily effective and low-cost biomarker of inflammatory status [5,6]. Previous studies have demonstrated its value in early prediction of infectious conditions [5,7], cancers [8][9][10][11][12][13] and cardiovascular diseases [14].…”
Section: Introductionmentioning
confidence: 99%
“…It can be caused either by heart infection (such as infectious endocarditis) or other chronic infectious diseases (COPD). In clinical practice, the neutrophil to lymphocyte ratio (NLR) is an easily effective and low-cost biomarker of inflammatory status [5,6]. Previous studies have demonstrated its value in early prediction of infectious conditions [5,7], cancers [8][9][10][11][12][13] and cardiovascular diseases [14].…”
Section: Introductionmentioning
confidence: 99%
“…In our study, we also found significant results for CRP, platelet, WBC and neutrophil values in addition to NLR when cases with AKI were compared to the non-AKI group [32]. In their letter to editor, Balta et al criticized some aspects of the study by Yılmaz et al Balta et al stated that NLR could not be a predictor in cases with AKI, because NLR can be affected by many factors including the methods used for phlebotomy, and NLR could be lower in patients receiving statin treatment and antihypertensive treatment (valsartan, nebivolol, amlodipin), and they stated that the results reported by Yılmaz et al [31] were not reliable, and that these results should be supported with other serum inflammation markers [33]. In our opinion, the critical reviews put forward by Balta et al are not justifiable.…”
Section: Discussionmentioning
confidence: 74%